JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204814200 on June 11, 2002

J. Biol. Chem., Vol. 277, Issue 34, 30832-30837, August 23, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/34/30832    most recent
M204814200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuo, J.
Right arrow Articles by Bohr, V. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Cockayne Syndrome Group B Gene Product Is Involved in Cellular Repair of 8-Hydroxyadenine in DNA*

Jingsheng TuoDagger , Pawel Jaruga§, Henry Rodriguez§, Miral Dizdaroglu§, and Vilhelm A. BohrDagger

From the Dagger  Laboratory of Molecular Gerontology, NIA, National Institutes of Health, Baltimore, Maryland 21224 and the § Chemical Science and Technology Laboratory, National Institute of Standards and Technology, Gaithersburg, Maryland 20899-8311

Received for publication, May 16, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cockayne syndrome (CS) is a human disease characterized by sensitivity to sunlight, severe neurological abnormalities, and accelerated aging. CS has two complementation groups, CS-A and CS-B. The CSB gene encodes the CSB protein with 1493 amino acids. We previously reported that the CSB protein is involved in cellular repair of 8-hydroxyguanine, an abundant lesion in oxidatively damaged DNA and that the putative helicase motif V/VI of the CSB may play a role in this process. The present study investigated the role of the CSB protein in cellular repair of 8-hydroxyadenine (8-OH-Ade), another abundant lesion in oxidatively damaged DNA. Extracts of CS-B-null cells and mutant cells with site-directed mutation in the motif VI of the putative helicase domain incised 8-hydroxyadenine in vitro less efficiently than wild type cells. Furthermore, CS-B-null and motif VI mutant cells accumulated more 8-hydroxyadenine in their genomic DNA than wild type cells after exposure to gamma -radiation at doses of 2 or 5 Gy. These results suggest that the CSB protein contributes to cellular repair of 8-OH-Ade and that the motif VI of the putative helicase domain of CSB is required for this activity.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cockayne syndrome (CS)1 is a human genetic disorder with diverse clinical symptoms (1). There are two complementation groups of CS, CS-A and CS-B. The CSB gene (CSB) encodes the CSB protein (CSB) with 1493 amino acids and a molecular mass of 168 kDa (2, 3). An important clinical feature of CS-B is accelerated aging. Thus, CS-B may be a useful model for studying the aging process in humans. Fibroblasts from CS-B patients are hypersensitive to ultraviolet (UV) radiation and show delayed recovery of RNA synthesis after exposure (1). CS-B cells have a pronounced defect in repair of UV radiation-induced DNA damage in actively transcribed genes (4). UV radiation-induced DNA damages are mostly bulky helix-distorting lesions that are removed by nucleotide-excision repair (NER). The transcription-coupled repair (TCR) pathway specifically removes these lesions in actively transcribed genes (5). CS-B cells are deficient in TCR, and this is thought to be the molecular basis of some features of the CS phenotype (6), especially the increased sensitivity to UV radiation. However, it is unlikely that the TCR defect and the resulting UV radiation sensitivity of CS-B cells account for other clinical features of CS such as progressive neurodegeneration. Thus, CS-B cells may be deficient in other processes besides TCR of UV radiation-induced DNA damage.

All organisms are continuously exposed to reactive oxygen species, which cause cellular damage and are thought to contribute to the aging process (7). Reactive oxygen species damage DNA and generate numerous DNA lesions such as modified bases and sugar moieties, strand breaks, and DNA-protein cross-links (reviewed in Ref. 8). 8-hydroxy-7,8-dihydroguanine (8-OH-Gua) is a ubiquitous lesion in oxidatively damaged DNA that is mutagenic, causing G right-arrow T transversions in vitro and in vivo (9, 10). 8-hydroxy-7,8-dihydroadenine (8-OH-Ade) is another common lesion formed in DNA exposed to oxidizing agents such as hydroxyl radicals in vitro and in vivo (reviewed in Ref. 8 and structure is shown in Fig. 1). 8-OH-Ade is premutagenic and induces A right-arrow G and A right-arrow C mutations in mammalian cells, although it leads to a lower mutation frequency than 8-OH-Gua (11-16). Nevertheless, the biological consequences of 8-OH-Ade could be significant, because it is abundant in oxidatively damaged DNA (17). 8-OH-Ade is repaired in mammalian cells (18), but the mechanism by which it is repaired is not known (19).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of 8-hydroxyadenine.

Studies suggest that oxidative damage to DNA may contribute to the premature aging phenotype associated with progeroid syndromes (20). Thus, it is possible that the DNA repair defect in CS plays an important role in the course and symptoms of this disorder. Whole cell extracts (WCEs) from primary CS-B cells incise 8-OH-Gua at a lower rate than normal cell lines, and this deficiency is complemented by transfection of the cells with wild type CSB (21). In addition, CS-B-null cells and CS-B motif V/VI mutants are more sensitive to gamma -radiation than wild type cells (22). WCEs from transfected CS-B-null cells and motif V/VI mutants also incise 8-OH-Gua-containing oligonucleotides less efficiently than wild type cells. Furthermore, 8-OH-Gua accumulates to a greater level in CS-B-null cells and motif VI mutants following gamma -irradiation than in wild type cells (22).

In this study, we investigated the role of CSB in cellular repair of 8-OH-Ade. CSB mutants were expressed in CS-B-null cells and in vitro incision of 8-OH-Ade was analyzed using WCEs from these cell lines. In addition, the nucleoside form of 8-OH-Ade, 8-hydroxy-2'-deoxyadenosine (8-OH-dAdo) was measured in genomic DNA of these cells by means of a recently developed assay that uses liquid chromatography/mass spectrometry (LC/MS) with the isotope dilution technique (17).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Lines and Culture Conditions-- Cell lines were derived from CS1AN.S3.G2, a SV40-transformed human fibroblast in which CSB is disrupted. These cells were described previously (23). CS1AN.S3.G2 was transfected with pcDNA3.1 carrying the wild type CSB, mutant CSB altered in the putative helicase motif VI (Q942E and R946A) or the vector pcDNA3.1 (pc3.1) (Invitrogen) (Fig. 2). The reason we applied Q942E and R946A is that these cell lines are the most deficient ones in repair of 8-OH-Gua among the 8 stably transfected cell lines established in this laboratory with site-directed mutation(s), which are distributed in various motifs of the helicase domain (22). Construction of the mutants and cell lines were described previously (22, 24).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 2.   Structure of CSB and the location of designed mutants. The protein contains the seven conserved helicase motifs, a highly acidic region, two nuclear localization signals (NLS), and a nucleotide binding domain (NTB). CSBQ942E is constructed by replacing a glutamine residue highly conserved in the SNF2 family with a negatively charged glutamic acid. CSBR946A is constructed by replacing an arginine residue highly conserved in the SNF2 family with alanine.

Exposure was carried out as follows. Cells attached on 10-cm2 dishes were washed with phosphate-buffered saline and then irradiated at the indicated doses with Gammacell 40 Exactor 137Cs gamma -source (Nordian International Inc., Kanata, Ontario, Canada) followed by incubation in the complete medium at 37 °C for 30 min. Genomic DNA was extracted as described (22).

In Vitro Incision of an 8-OH-Ade-containing Oligonucleotide-- An oligonucleotide with a single 8-OH-Ade at position 11 was the substrate for the incision assay. The sequences of the oligonucleotide used in the incision assay are listed in Table I. The oligonucleotide with the lesion was 32P-5'-end-labeled and annealed with a complementary strand containing a T opposite 8-OH-Ade. We also used a double-stranded substrate containing C opposite the lesion because this structure is the optimal substrate for nick-forming activity at position of 8-OH-Ade (25, 26). Incision reactions were carried out in a volume of 20 µl containing 100 fmol of oligonucleotide duplex, 1 µg of poly(dIdC) competitor, 20 mM Hepes-KOH, pH 7.8, 100 mM KCl, 5 mM dithiothreitol, 5 mM EDTA, 2 mM MgCl2, and 40 µg of WCE protein prepared as described (22, 27). Reactions were incubated at 37 °C for 3 h, terminated by the addition of 0.8 µl of 10% SDS and 0.8 µl of 5 mg/ml proteinase K, and incubated for 10 min at 55 °C. DNA was precipitated with 2 µl of 5 mg/ml glycogen (Ambion), 4 µl of 11 M ammonium acetate, and 70 µl of cold ethanol overnight at -20 °C. Samples were centrifuged for 1 h at 4 °C, washed with 200 µl of 70% ethanol, and collected by centrifugation at 12,000 × g for 10 min. The pellet was dried in a speed-vacuum and resuspended in 10 µl of formamide-loading dye (5% EDTA, 0.02% bromphenol blue, 0.02% xylene cyanol in 95% formamide). Samples were separated on a denaturing 20% polyacrylamide gel (containing 7 M urea, 89 mM Tris borate, pH 8.0, and 2 mM EDTA). The reaction products were visualized by autoradiography and quantified on a PhosphorImager (Molecular Dynamics). Oligonucleotides containing a single uracil or 5-hydroxycytosine, which were known to have no differences in incision activity of our CS-B wild type, null, or mutant cell lines, were used as the WCE control (22).

                              
View this table:
[in this window]
[in a new window]
 
Table I
The oligonucleotides used in incision assay

LC/MS and Preparation of the Stable Isotope-labeled Analog of 8-OH-dAdo-- The measurement of 8-OH-dAdo in enzymic hydrolysates of DNA samples was performed by liquid chromatography/isotope-dilution mass spectrometry (LC/IDMS) as previously described except for the stable isotope-labeled internal standard, which was used for quantification by IDMS (17). In the present work, a stable isotope-labeled analog of 8-OH-dAdo was prepared and isolated in pure form. Commercially available [15N5]dATP (Medical Isotopes, Inc. Pelham, NH) was used as the starting material. An aqueous solution of [15N5]dATP (5 mg/100 ml) was bubbled with N2O and exposed to ionizing radiation in a 60Co gamma -source at a dose of 400 Gy (30 Gy/min). This treatment was expected to produce 8-OH-[15N5]dATP from [15N5]dATP among other products, because it is well known that the exposure of aqueous solutions of dAdo to ionizing radiation generates 8-OH-dAdo (reviewed in Refs. 28 and 29). 8-OH-[15N5]dATP was dephosphorylated to 8-OH-[15N5]dAdo as follows: an aliquot of 100 ml of the irradiated solution of [15N5]dATP was lyophilized to dryness, dissolved in 1 ml of 10 mM phosphate buffer (pH 8.0), and incubated with alkaline phosphatase (5 units) at 37 °C for 24 h. The sample was filtered by centrifugation at 6000 × g for 30 min through an ultrafiltration membrane with a molecular mass cutoff of 5 kDa (Millipore Corp., Bedford, MA). An aliquot (5 µl) of the filtered sample was analyzed by LC/MS and found to contain 8-OH-[15N5]dAdo on the basis of the previously reported LC/MS analysis of 8-OH-Ado (17). Semipreparative LC was used to isolate 8-OH-[15N5]dAdo from an irradiated and dephosphorylated sample of [15N5]dATP using a Supelcosil LC-8 DB reversed-phase column (25 × 1 cm inner diameter, 5-µm particle size) (Supelco, Bellefonte, PA). The solvents and the elution gradient were as previously described (17), except that a flow rate of 2 ml/min was used. The column was kept at room temperature. Under the experimental conditions used, 8-OH-[15N5]dAdo eluting at 18.3 min was completely separated from [15N5]dAdo, which eluted at 17.3 min. This is the same elution order previously described for the unlabeled analogues of these compounds using an analytical LC column (17). The fractions corresponding to 8-OH-[15N5]dAdo were collected. At least 30 injections of 100 µl were performed. Collected fractions were combined, dried in a SpeedVac under vacuum, and then dissolved in 200 µl of water. The absorption spectrum of the solution was recorded between the wavelengths of 210 and 350 nm. The spectrum was identical to the absorption spectrum of authentic 8-OH-dAdo (30).

Analytical LC/MS was carried out to confirm the identity of 8-OH-[15N5]dAdo and its purity. The isolated compound was pure and did not contain any detectable unlabeled 8-OH-dAdo. The elution time of 8-OH-[15N5]dAdo was the same as that of 8-OH-dAdo, and its mass spectrum was similar to that of 8-OH-dAdo (17). As expected, however, the masses of the typical ions of 8-OH-[15N5]dAdo were shifted by 5 Da to greater masses, i.e. m/z 157 (the protonated base ion (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>)), 273 (the protonated molecular ion (MH+)), and 295 (the sodium adduct ion (MNa+)). The concentration of the solution of 8-OH-[15N5]dAdo was determined by UV spectrophotometer using the absorption coefficient of 12764 M-1 cm-1 at 270 nm (30) and by LC/MS using a 0.1 mM solution of 8-OH-dAdo as an internal standard. Both measurements yielded essentially identical results. The concentration of the solution of 8-OH-[15N5]dAdo was 0.037 ± 0.003 mM.

8-OH-dAdo was measured in DNA samples spiked with 2 pmol of 8-OH-[15N5]dAdo per 70 µg of DNA. The concentration of DNA samples was determined by UV spectrophotometry. DNA samples were hydrolyzed with nuclease P1, phosphodiesterase I, and alkaline phosphatase as described (17) and filtered by centrifugation at 6000 × g for 30 min using an ultrafiltration membrane with a molecular mass cutoff of 5 kDa. An aliquot of 20 µl of the filtered samples containing 20 µg of hydrolyzed DNA was injected on the LC column. Characteristic ions of 8-OH-dAdo at m/z 152 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>), 268 (MH+), and 290 (MNa+), and those of 8-OH-[15N5]dAdo at m/z 157 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>), 273 (MH+), and 295 (MNa+) were recorded during LC/MS analysis using the selected-ion monitoring (SIM) mode at the retention time period, when these compounds eluted.

Statistics-- Groups were compared using one-way analysis of variance tests. Duncan's multiple range test was used for post-hoc comparison of means. Differences were considered significant when p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we investigated the possibility that CSB is involved in cellular repair of 8-OH-Ade, a major lesion in oxidatively damaged DNA. 8-OH-Ade repair was assessed and compared in wild type, CS-B-null, and putative CS-B helicase motif VI mutant cells. Glycosylase/apurinic lyase activity in CS-B cell lines was quantified by measuring incision of an oligonucleotide with a single 8-OH-Ade residue. Fig. 3A shows the incision activity of wild type, CS-B-null, and two CS-B mutant cell lines, and the results are summarized in Fig. 3B. Fig. 4, A and B show similar results, the only difference being that we used the substrate with C opposite the 8-OH-Ade lesion to possibly generate maximal nick-forming activity (25, 26). CS-B-null and mutant cell lines incise 8-OH-Ade less efficiently than wild type cells in both situations. The activity of CS-B-null cells was ~3-fold lower than wild type cells (p < 0.05), and the activity of motif VI mutants (CSBQ942E and CSBR946A) was ~2-fold lower than wild type cells (p < 0.05). There were no differences in uracil or 5-hydroxycytocine incision of WCE of the tested cell lines (data not shown) (22).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   Glycosylase/apurinic lyase activities on 8-OH-Ade in wild type and CSB mutant cells. The substrate contained T paired with 8-OH-Ade. A, incubations were carried out for 3 h, and reaction products were analyzed by denaturing polyacrylamide gel electrophoresis. The substrate is a 28-mer, and the product is 11-mer. B, quantification of 8-OH-Ade glycosylase/apurinic lyase activity. The mean values (± S.D.) from four independent experiments are shown. Asterisks indicate values that are significantly different from CSBWT (p < 0.05).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 4.   Structure of CSB and the location of designed mutants, but the substrate used contains a C opposite the 8-OH-Ade lesion.

The role of CSB in repairing 8-OH-Ade was also examined by measuring the level of 8-OH-Ade in DNA of cells exposed to gamma -radiation at doses of 2 or 5 Gy. 8-OH-Ade was measured as its nucleoside 8-OH-dAdo in wild type, CS-B-null, motif VI mutant cells using LC/IDMS, a recently developed assay for identification and quantification of oxidatively modified DNA nucleosides (17). DNA samples isolated from cells were hydrolyzed to nucleosides by endo- and exonucleases. Prior to hydrolysis, an aliquot of 8-OH-[15N5]dAdo was added as internal standard to the DNA samples. LC/IDMS was carried out in SIM mode to monitor the characteristic ions of 8-OH-dAdo and 8-OH-[15N5]dAdo at the appropriate retention time period, when these compounds eluted. The BH<UP><SUB>2</SUB><SUP>+</SUP></UP>, MH+, and MNa+ ions of both compounds were simultaneously recorded. As expected, no difference between the retention times of these analogues was observed. Fig. 5 shows the ion-current profiles at m/z 152 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>) and m/z 290 (MNa+) of 8-OH-dAdo and at m/z 157 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>) and m/z 295 (MNa+) of 8-OH-[15N5]dAdo, recorded during the LC/IDMS-SIM analysis of the enzymic hydrolysate of a DNA sample isolated from CSBQ942E cells following gamma -radiation at 2 Gy. The results showed unequivocal identification of 8-OH-dAdo in DNA from all cell lines used in this study. The quantification was achieved by the integration of the signals of the monitored ions such as those in Fig. 5 and the calculation of the level of 8-OH-dAdo on the basis of the known amount of 8-OH-[15N5]dAdo added to the DNA samples as an internal standard prior to enzymic hydrolysis.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5.   Measurement of 8-OH-dAdo by LC/IDMS in genomic DNA of wild type and CSB mutant cells. Selected ion-current profiles at m/z 152 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>) and m/z 290 (MNa+) of 8-OH-dAdo, and at m/z 157 (BH<UP><SUB>2</SUB><SUP>+</SUP></UP>) and m/z 295 (MNa+) of 8-OH-[15N5]dAdo, which were recorded during the LC/IDMS-SIM analysis of the enzymic hydrolysate of a DNA sample isolated from CSBQ942E cells following gamma -irradiation at 2 Gy.

Fig. 6 shows the level of 8-OH-dAdo in cells following exposure to ionizing radiation. Cells were irradiated and allowed 30 min to recover and repair radiation-induced DNA damage. The level of 8-OH-dAdo was similar (~0.7 molecules/106 DNA nucleosides) in genomic DNA of non-irradiated cells regardless of genotype. No change in the 8-OH-dAdo level was observed in gamma -irradiated wild type cells, indicating complete and rapid repair of this lesion. The time of complete repair within 30 min is in agreement with the recently reported repair kinetics of 8-OH-Ade in human cells (18). In contrast, significantly greater levels of 8-OH-dAdo were observed in gamma -irradiated CS-B-null and motif VI mutant cells. In motif VI mutants, exposure to gamma -radiation at 5 Gy followed by a 30-min incubation resulted in a higher level of 8-OH-dAdo than exposure to gamma -radiation at 2 Gy. These results demonstrate that 8-OH-dAdo accumulates in a dose-dependent manner in irradiated mutant cells but does not accumulate in irradiated wild type cells.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   Level of 8-OH-dAdo in genomic DNA of gamma -irradiated wild type and CSB mutant cells. Cells were exposed to gamma -radiation at doses of 2 or 5 Gy and subsequently incubated for 30 min. DNA was isolated and analyzed for 8-OH-dAdo as described above. The data shown represent the mean values (± S.D.) of four independent experiments. Asterisks indicate values that are significantly different from CSBWT (p < 0.05).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Previous studies have shown that mutations in CSB cause a deficiency in cellular repair of 8-OH-Gua (22). The present study shows that CS-B-null and motif VI mutant cells are also deficient in incision of 8-OH-Ade. Consistent with this observation, 8-OH-Ade accumulates more in genomic DNA of CS-B-null and motif VI mutant cells than in wild type cells following exposure of cells to gamma -radiation at low doses. These results suggest that CS-B-null and motif VI mutant cells are deficient in cellular repair of 8-OH-Ade. This in turn indicates that CSB plays an important role in cellular repair of 8-OH-Ade and that the putative helicase motif VI of CSB is important for this DNA repair function.

CSB is highly homologous to proteins of the SWI/SNF2 family (2, 3, 31). SWI/SNF proteins participate in a wide variety of cellular functions including DNA repair, regulation of transcription, maintenance of chromosome stability, and chromatin remodeling (5, 31-33). SWI/SNF2 proteins contain seven highly conserved motifs for DNA or RNA helicase activity (2, 32), but so far, none has been shown to have this function. Previous experiments were carried out to characterize the cellular response of various CS-B mutant cell lines to different challenges (Table II) (22, 24, 34). We have also mapped the CSB putative helicase motifs and determined their role in cellular repair of 8-OH-Gua (Table II). Those experiments showed that motifs V and VI are essential for the cellular response to oxidative stress and for cellular repair of 8-OH-Gua in genomic DNA. The results presented here show that CSB motif VI also plays an important role in cellular repair of 8-OH-Ade.

                              
View this table:
[in this window]
[in a new window]
 
Table II
The biological consequences of mutation(s) of putative helicase motifs of CSB in various assays

It is not clear what mechanism underlies the role of CSB in the repair of 8-OH-Gua and 8-OH-Ade. The enzymes involved specifically in repair of 8-OH-Ade have not yet been identified (reviewed in Ref. 19), but some evidence suggests that repair of 8-OH-Ade is mechanistically different from repair of 8-OH-Gua. Among the bacterial and mammalian DNA glycosylases, which were investigated for their activity on lesions in oxidatively damaged DNA, only Escherichia coli formamidopyrimidine glycosylase (Fpg) exhibited a low activity on 8-OH-Ade in DNA containing multiple modified bases (35, 36). However, this activity was insignificant when compared with the activity of Fpg on 8-OH-Gua, 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua), and 4,6-diamino-5-formamidopyrimidine (FapyAde), which are the principal substrates of Fpg. The inactivity of Fpg was suggested to result from the absence of a C6-keto group in 8-OH-Ade (37). A recent study on the cellular repair of modified DNA bases showed that 8-OH-Ade is efficiently repaired in human cells with kinetics similar to the repair kinetics of pyrimidine-derived lesions rather than to that of purine-derived lesions (18). This suggests that human cells possess enzyme(s) to repair 8-OH-Ade. However, it is not known whether this repair activity involves BER or NER, or both. A yeast functional homolog of E. coli Fpg encoded by the OGG1 gene of Saccharomyces cerevisiae (yOgg1) was shown to excise 8-OH-Gua and FapyGua, but not FapyAde or 8-OH-Ade (38, 39). Human homologues of yOgg1 were recently isolated (reviewed in Ref. 40). Two polymorphic forms of hOgg1 namely alpha -hOgg1-Ser326 and alpha -hOgg1-Cys326 are produced in human cells. Similar to yOgg1, both enzymes were reported to efficiently excise 8-OH-Gua and FapyGua, but not FapyAde or 8-OH-Ade from DNA with multiple lesions (41). Two enzymes from Drosophila melanogaster also exhibited similar activities that efficiently excised 8-OH-Gua and FapyGua from DNA, but not FapyAde and 8-OH-Ade (42, 43). In the same context, it should be pointed out, that although 8-OH-Ade was repaired in human cells with kinetics similar to repair kinetics of pyrimidine-derived lesions, none of the known pyrimidine lesion-specific DNA glycosylases removed 8-OH-Ade from DNA either (reviewed in Ref. 19). These studies clearly show that there is a paucity of knowledge about enzymes that repair 8-OH-Ade in cells or in vitro. On the other hand, our results confirm results from the previous study on the cellular repair of 8-OH-Ade in terms of the ability of human cells to repair this lesion and in terms of its repair kinetics (18). By studying the biochemical contribution and expression regulation of CSB to cellular repair of 8-OH-Gua, we found that CSB itself participates in the catalytic process of 8-OH-Gua incision in vitro, and CSB facilitates the expression of hOgg1.2 Further research is necessary to understand the mechanism by which CSB facilitates cellular repair of 8-OH-Ade and to identify other proteins that might contribute directly or indirectly to cellular repair of this lesion.

8-OH-Ade was identified as its nucleoside form 8-OH-dAdo, and its level and accumulation in genomic DNA of CS-B mutant cells was quantified by means of a recently developed methodology using LC/IDMS (44). The present study is the first application of this technique to the measurement of the formation and repair of 8-OH-dAdo in living cells. The specificity and sensitivity of LC/IDMS in the SIM mode permitted us to detect and quantify 8-OH-dAdo at a level of ~7 molecules/107 DNA nucleosides. Such a level of detection by LC/IDMS-SIM had previously been reported (44). For quantification, we isolated a stable isotope-labeled analog of 8-OH-dAdo in pure form for the first time and used it as the internal standard. It should be pointed out that the use of liquid chromatography/tandem mass spectrometry (LC/MS/MS) has also been reported for the identification of 8-OH-dAdo (45-48). However, the isotope-dilution technique has been applied for quantification in two instances only (45, 48). The sensitivity level for 8-OH-dAdo of this technique in the multiple reaction-monitoring (MRM) mode is similar to that of LC/IDMS-SIM (17). On the other hand, the application of LC/MS/MS-MRM to the measurement of 8-OH-dAdo in living cells has not been reported.

In conclusion, the present study suggests that CSB plays a role in the cellular repair of 8-OH-Ade and that the putative helicase motif VI of CSB may be important in this process. In addition, 8-OH-Ade and other lesions such as 8-OH-Gua might accumulate in the DNA of CS patients and could potentially contribute to pathology associated with CS.

    ACKNOWLEDGEMENTS

We thank Dr. C. Chen for DNA extraction.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 410-558-8223; Fax: 410-558-8157; E-mail: vbohr@nih.gov.

Published, JBC Papers in Press, June 11, 2002, DOI 10.1074/jbc.M204814200

2 J. Tuo, C. Chen, X. Zeng, M. Christiansen, and V. A. Bohr, unpublished data.

    ABBREVIATIONS

The abbreviations used are: CS, Cockayne syndrome; CS-B, Cockayne syndrome group B; BER, base-excision repair; NER, nucleotide-excision repair; TCR, transcription-coupled repair; 8-OH-Ade, 8-hydroxyadenine; 8-OH-dAdo, 8-hydroxy-2'-deoxyadenosine; 8-OH-Gua, 8-hydroxyguanine; 8-OH-dGuo, 8-hydroxy-2'-deoxyguanosine; WCE, whole cell extract; LC/MS, liquid chromatography/mass spectrometry; IDMS, isotope-dilution MS; SIM, selected-ion monitoring; hOGG1, 8-OH-Gua glycosylase/apurinic lyase; 4-NQO, 4-nitroquinoline-1-oxide; Gy, Gray.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Friedberg, E. C. (1996) Bioessays 18, 731-738[CrossRef][Medline] [Order article via Infotrieve]
2. Troelstra, C., Odijk, H., de Wit, J., Westerveld, A., Thompson, L. H., Bootsma, D., and Hoeijmakers, J. H. (1990) Mol. Cell. Biol. 10, 5806-5813[Abstract/Free Full Text]
3. Troelstra, C., van Gool, A., de Wit, J., Vermeulen, W., Bootsma, D., and Hoeijmakers, J. H. (1992) Cell 71, 939-953[CrossRef][Medline] [Order article via Infotrieve]
4. Venema, J., Mullenders, L. H., Natarajan, A. T., van Zeeland, A. A., and Mayne, L. V. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4707-4711[Abstract/Free Full Text]
5. Balajee, A. S., and Bohr, V. A. (2000) Gene (Amst.) 250, 15-30[CrossRef][Medline] [Order article via Infotrieve]
6. van Hoffen, A., Natarajan, A. T., Mayne, L. V., van Zeeland, A. A., Mullenders, L. H., and Venema, J. (1993) Nucleic Acids Res. 21, 5890-5895[Abstract/Free Full Text]
7. Halliwell, B., and Gutteridge, J. M. (1990) Methods Enzymol. 186, 1-85[CrossRef][Medline] [Order article via Infotrieve]
8. Dizdaroglu, M. (1998) Free Radic. Res. 29, 551-563[CrossRef][Medline] [Order article via Infotrieve]
9. Le Page, F., Margot, A., Grollman, A. P., Sarasin, A., and Gentil, A. (1995) Carcinogenesis 16, 2779-2784[Abstract/Free Full Text]
10. Shibutani, S., Takeshita, M., and Grollman, A. P. (1991) Nature 349, 431-434[CrossRef][Medline] [Order article via Infotrieve]
11. Guschlbauer, W., Duplaa, A. M., Guy, A., Teoule, R., and Fazakerley, G. V. (1991) Nucleic Acids Res. 19, 1753-1758[Abstract/Free Full Text]
12. Kamiya, H., Miura, H., Murata-Kamiya, N., Ishikawa, H., Sakaguchi, T., Inoue, H., Sasaki, T., Masutani, C., Hanaoka, F., and Nishimura, S. (1995) Nucleic Acids Res. 23, 2893-2899[Abstract/Free Full Text]
13. Shibutani, S., Bodepudi, V., Johnson, F., and Grollman, A. P. (1993) Biochemistry 32, 4615-4621[CrossRef][Medline] [Order article via Infotrieve]
14. Tan, X., Grollman, A. P., and Shibutani, S. (1999) Carcinogenesis 20, 2287-2292[Abstract/Free Full Text]
15. Wang, D., Kreutzer, D. A., and Essigmann, J. M. (1998) Mutat. Res. 400, 99-115[Medline] [Order article via Infotrieve]
16. Wood, M. L., Esteve, A., Morningstar, M. L., Kuziemko, G. M., and Essigmann, J. M. (1992) Nucleic Acids Res. 20, 6023-6032[Abstract/Free Full Text]
17. Jaruga, P., Rodriguez, H., and Dizdaroglu, M. (2001) Free Radic. Biol. Med. 31, 336-344[CrossRef][Medline] [Order article via Infotrieve]
18. Jaruga, P., and Dizdaroglu, M. (1996) Nucleic Acids Res. 24, 1389-1394[Abstract/Free Full Text]
19. Dizdaroglu, M. (2001) in Free Radicals in Chemistry, Biology and Medicine (Yoshikawa, T. , Toyokuni, S. , Yamamoto, Y. , and Naito, Y., eds) , pp. 58-76, OICA International, London
20. Kipling, D., and Faragher, R. G. (1997) Mol. Pathol. 50, 234-241[Abstract/Free Full Text]
21. Dianov, G., Bischoff, C., Sunesen, M., and Bohr, V. A. (1999) Nucleic Acids Res. 27, 1365-1368[Abstract/Free Full Text]
22. Tuo, J., Muftuoglu, M., Chen, C., Jaruga, P., Selzer, R. R., Brosh, R. M., Jr., Rodriguez, H., Dizdaroglu, M., and Bohr, V. A. (2001) J. Biol. Chem. 276, 45772-45779[Abstract/Free Full Text]
23. Mayne, L. V., Priestley, A., James, M. R., and Burke, J. F. (1986) Exp. Cell Res. 162, 530-538[CrossRef][Medline] [Order article via Infotrieve]
24. Muftuoglu, M., Selzer1 R, Tuo, J., Brosh, R. M., and Bohr, V. A. (2002) Gene (Amst.) 283, 27-40[CrossRef][Medline] [Order article via Infotrieve]
25. Girard, P. M., D'Ham, C., Cadet, J., and Boiteux, S. (1998) Carcinogenesis 19, 1299-1305[Abstract/Free Full Text]
26. Zharkov, D. O., Rosenquist, T. A., Gerchman, S. E., and Grollman, A. P. (2000) J. Biol. Chem. 275, 28607-28617[Abstract/Free Full Text]
27. Manley, J. L., Fire, A., Samuels, M., and Sharp, P. A. (1983) Methods Enzymol. 101, 568-582[Medline] [Order article via Infotrieve]
28. Breen, A. P., and Murphy, J. A. (1995) Free Radic. Biol. Med. 18, 1033-1077[CrossRef][Medline] [Order article via Infotrieve]
29. Dizdaroglu, M. (1992) Mutat. Res. 275, 331-342[CrossRef][Medline] [Order article via Infotrieve]
30. Cavalieri, L. F., and Bendich, A. (1950) J. Am. Chem. Soc. 72, 2587-2594[CrossRef]
31. Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., and Blinov, V. M. (1989) Nucleic Acids Res. 17, 4713-4730[Abstract/Free Full Text]
32. Eisen, J. A., Sweder, K. S., and Hanawalt, P. C. (1995) Nucleic Acids Res. 23, 2715-2723[Abstract/Free Full Text]
33. Pazin, M. J., and Kadonaga, J. T. (1997) Cell 88, 737-740[CrossRef][Medline] [Order article via Infotrieve]
34. Selzer, R. R., Nyaga, S., Tuo, J., May, A., Muftuoglu, M., Christiansen, M., Citterio, E., Brosh, R. M., Jr., and Bohr, V. A. (2002) Nucleic Acids Res. 30, 782-793[Abstract/Free Full Text]
35. Boiteux, S., Gajewski, E., Laval, J., and Dizdaroglu, M. (1992) Biochemistry 31, 106-110[CrossRef][Medline] [Order article via Infotrieve]
36. Karakaya, A., Jaruga, P., Bohr, V. A., Grollman, A. P., and Dizdaroglu, M. (1997) Nucleic Acids Res. 25, 474-479[Abstract/Free Full Text]
37. Tchou, J., Bodepudi, V., Shibutani, S., Antoshechkin, I., Miller, J., Grollman, A. P., and Johnson, F. (1994) J. Biol. Chem. 269, 15318-15324[Abstract/Free Full Text]
38. Karahalil, B., Girard, P. M., Boiteux, S., and Dizdaroglu, M. (1998) Nucleic Acids Res. 26, 1228-1233[Abstract/Free Full Text]
39. van der Kemp, P. A., Thomas, D., Barbey, R., De, Oliveira, R., and Boiteux, S. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5197-5202[Abstract/Free Full Text]
40. Boiteux, S., and Radicella, J. P. (1999) Biochimie (Paris) 81, 59-67[Medline] [Order article via Infotrieve]
41. Dherin, C., Radicella, J. P., Dizdaroglu, M., and Boiteux, S. (1999) Nucleic Acids Res. 27, 4001-4007[Abstract/Free Full Text]
42. Deutsch, W. A., Yacoub, A., Jaruga, P., Zastawny, T. H., and Dizdaroglu, M. (1997) J. Biol. Chem. 272, 32857-32860[Abstract/Free Full Text]
43. Dherin, C., Dizdaroglu, M., Doerflinger, H., Boiteux, S., and Radicella, J. P. (2000) Nucleic Acids Res. 28, 4583-4592[Abstract/Free Full Text]
44. Jaiswal, M., LaRusso, N. F., Nishioka, N., Nakabeppu, Y., and Gores, G. J. (2001) Cancer Res. 61, 6388-6393[Abstract/Free Full Text]
45. Frelon, S., Douki, T., Ravanat, J. L., Pouget, J. P., Tornabene, C., and Cadet, J. (2000) Chem Res. Toxicol. 13, 1002-1010[CrossRef][Medline] [Order article via Infotrieve]
46. Hua, Y., Wainhaus, S. B., Yang, Y., Shen, L., Xiong, Y., Xu, X., Zhang, F., Bolton, J. L., and van Breemen, R. B. (2001) J Am. Soc. Mass Spectrom. 12, 80-87[CrossRef][Medline] [Order article via Infotrieve]
47. Podmore, I. D., Cooper, D., Evans, M. D., Wood, M., and Lunec, J. (2000) Biochem. Biophys. Res. Commun. 277, 764-770[CrossRef][Medline] [Order article via Infotrieve]
48. Weimann, A., Belling, D., and Poulsen, H. E. (2001) Free Radic. Biol. Med. 30, 757-764[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Menoni, D. Gasparutto, A. Hamiche, J. Cadet, S. Dimitrov, P. Bouvet, and D. Angelov
ATP-Dependent Chromatin Remodeling Is Required for Base Excision Repair in Conventional but Not in Variant H2A.Bbd Nucleosomes
Mol. Cell. Biol., September 1, 2007; 27(17): 5949 - 5956.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Z. Imam, F. E. Indig, W.-H. Cheng, S. P. Saxena, T. Stevnsner, D. Kufe, and V. A. Bohr
Cockayne syndrome protein B interacts with and is phosphorylated by c-Abl tyrosine kinase
Nucleic Acids Res., August 1, 2007; 35(15): 4941 - 4951.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Newman, A. D. Bailey, and A. M. Weiner
Cockayne syndrome group B protein (CSB) plays a general role in chromatin maintenance and remodeling
PNAS, June 20, 2006; 103(25): 9613 - 9618.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Muftuoglu, S. Sharma, T. Thorslund, T. Stevnsner, M. M. Soerensen, R. M. Brosh Jr, and V. A. Bohr
Cockayne syndrome group B protein has novel strand annealing and exchange activities
Nucleic Acids Res., January 12, 2006; 34(1): 295 - 304.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Horibata, Y. Iwamoto, I. Kuraoka, N. G. J. Jaspers, A. Kurimasa, M. Oshimura, M. Ichihashi, and K. Tanaka
From The Cover: Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome
PNAS, October 26, 2004; 101(43): 15410 - 15415.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. R. Trzeciak, S. G. Nyaga, P. Jaruga, A. Lohani, M. Dizdaroglu, and M. K. Evans
Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145
Carcinogenesis, August 1, 2004; 25(8): 1359 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. L. Peterson and J. Cote
Cellular machineries for chromosomal DNA repair
Genes & Dev., March 15, 2004; 18(6): 602 - 616.
[Full Text] [PDF]


Home page
FASEB J.Home page
M. S. COOKE, M. D. EVANS, M. DIZDAROGLU, and J. LUNEC
Oxidative DNA damage: mechanisms, mutation, and disease
FASEB J, July 1, 2003; 17(10): 1195 - 1214.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Jensen, G. Calvayrac, B. Karahalil, V. A. Bohr, and T. Stevnsner
Mammalian 8-Oxoguanine DNA Glycosylase 1 Incises 8-Oxoadenine Opposite Cytosine in Nuclei and Mitochondria, while a Different Glycosylase Incises 8-Oxoadenine Opposite Guanine in Nuclei
J. Biol. Chem., May 23, 2003; 278(21): 19541 - 19548.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. TUO, P. JARUGA, H. RODRIGUEZ, V. A. BOHR, and M. DIZDAROGLU
Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress
FASEB J, April 1, 2003; 17(6): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Christiansen, T. Stevnsner, C. Modin, P. M. Martensen, R. M. Brosh Jr, and V. A. Bohr
Functional consequences of mutations in the conserved SF2 motifs and post-translational phosphorylation of the CSB protein
Nucleic Acids Res., February 1, 2003; 31(3): 963 - 973.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/34/30832    most recent
M204814200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow